Internal en bloc resection and genetic analysis of retinal capillary hemangioblastoma

Thomas Schlesinger, Binoy Appukuttan, Thomas Hwang, La Ongsri Atchaneeyakasul, Chi Chao Chan, Zhengping Zhuang, J. Timothy Stout, David Wilson

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Objective: To report the clinical outcomes and molecular genetics of nongermline retinal hemangioblastoma managed by surgical resection. Methods: Retrospective case series of 3 patients aged 16 to 46 years treated at a tertiary care referral center (Casey Eye Institute, Portland, Oregon). Tumors 7 to 9 mm in diameter were removed from 3 consecutive eyes (in 3 patients) via internal en bloc surgical resection using a bimanual technique. Samples of DNA from 2 of 3 tumors were tested for von Hippel-Lindau gene (VHL) mutations as a clue to the molecular basis for spontaneously occurring hemangioblastoma. Main outcome measures were morbidity, visual acuity, resolution of macular exudates, and presence of VHL markers. Results: Visual acuity improved or remained stable in all patients. All 3 developed cataracts, extracted in 2 instances. Histopathological findings were typical of retinal hemangioblastoma in all cases. The cells from one patient's DNA sample showed loss of heterozygosity for the VHL gene, while no genetic abnormalities were detected in the other patient's DNA sample. Conclusions: Our patients' favorable outcomes suggest that surgical resection is an option for patients with large retinal hemangioblastomas. In addition, ours may be the first report of retinal hemangioblastoma unassociated with a VHL mutation.

Original languageEnglish (US)
Pages (from-to)1189-1193
Number of pages5
JournalArchives of Ophthalmology
Volume125
Issue number9
DOIs
StatePublished - Sep 2007

Fingerprint

Hemangioblastoma
Genes
Tertiary Care Centers
Visual Acuity
DNA
Mutation
Loss of Heterozygosity
Exudates and Transudates
Cataract
Molecular Biology
Neoplasms
Outcome Assessment (Health Care)
Morbidity

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Internal en bloc resection and genetic analysis of retinal capillary hemangioblastoma. / Schlesinger, Thomas; Appukuttan, Binoy; Hwang, Thomas; Atchaneeyakasul, La Ongsri; Chan, Chi Chao; Zhuang, Zhengping; Stout, J. Timothy; Wilson, David.

In: Archives of Ophthalmology, Vol. 125, No. 9, 09.2007, p. 1189-1193.

Research output: Contribution to journalArticle

Schlesinger, T, Appukuttan, B, Hwang, T, Atchaneeyakasul, LO, Chan, CC, Zhuang, Z, Stout, JT & Wilson, D 2007, 'Internal en bloc resection and genetic analysis of retinal capillary hemangioblastoma', Archives of Ophthalmology, vol. 125, no. 9, pp. 1189-1193. https://doi.org/10.1001/archopht.125.9.1189
Schlesinger, Thomas ; Appukuttan, Binoy ; Hwang, Thomas ; Atchaneeyakasul, La Ongsri ; Chan, Chi Chao ; Zhuang, Zhengping ; Stout, J. Timothy ; Wilson, David. / Internal en bloc resection and genetic analysis of retinal capillary hemangioblastoma. In: Archives of Ophthalmology. 2007 ; Vol. 125, No. 9. pp. 1189-1193.
@article{8f7004d9a18a4d75aef5c1f26d22cbe7,
title = "Internal en bloc resection and genetic analysis of retinal capillary hemangioblastoma",
abstract = "Objective: To report the clinical outcomes and molecular genetics of nongermline retinal hemangioblastoma managed by surgical resection. Methods: Retrospective case series of 3 patients aged 16 to 46 years treated at a tertiary care referral center (Casey Eye Institute, Portland, Oregon). Tumors 7 to 9 mm in diameter were removed from 3 consecutive eyes (in 3 patients) via internal en bloc surgical resection using a bimanual technique. Samples of DNA from 2 of 3 tumors were tested for von Hippel-Lindau gene (VHL) mutations as a clue to the molecular basis for spontaneously occurring hemangioblastoma. Main outcome measures were morbidity, visual acuity, resolution of macular exudates, and presence of VHL markers. Results: Visual acuity improved or remained stable in all patients. All 3 developed cataracts, extracted in 2 instances. Histopathological findings were typical of retinal hemangioblastoma in all cases. The cells from one patient's DNA sample showed loss of heterozygosity for the VHL gene, while no genetic abnormalities were detected in the other patient's DNA sample. Conclusions: Our patients' favorable outcomes suggest that surgical resection is an option for patients with large retinal hemangioblastomas. In addition, ours may be the first report of retinal hemangioblastoma unassociated with a VHL mutation.",
author = "Thomas Schlesinger and Binoy Appukuttan and Thomas Hwang and Atchaneeyakasul, {La Ongsri} and Chan, {Chi Chao} and Zhengping Zhuang and Stout, {J. Timothy} and David Wilson",
year = "2007",
month = "9",
doi = "10.1001/archopht.125.9.1189",
language = "English (US)",
volume = "125",
pages = "1189--1193",
journal = "JAMA Ophthalmology",
issn = "2168-6165",
publisher = "American Medical Association",
number = "9",

}

TY - JOUR

T1 - Internal en bloc resection and genetic analysis of retinal capillary hemangioblastoma

AU - Schlesinger, Thomas

AU - Appukuttan, Binoy

AU - Hwang, Thomas

AU - Atchaneeyakasul, La Ongsri

AU - Chan, Chi Chao

AU - Zhuang, Zhengping

AU - Stout, J. Timothy

AU - Wilson, David

PY - 2007/9

Y1 - 2007/9

N2 - Objective: To report the clinical outcomes and molecular genetics of nongermline retinal hemangioblastoma managed by surgical resection. Methods: Retrospective case series of 3 patients aged 16 to 46 years treated at a tertiary care referral center (Casey Eye Institute, Portland, Oregon). Tumors 7 to 9 mm in diameter were removed from 3 consecutive eyes (in 3 patients) via internal en bloc surgical resection using a bimanual technique. Samples of DNA from 2 of 3 tumors were tested for von Hippel-Lindau gene (VHL) mutations as a clue to the molecular basis for spontaneously occurring hemangioblastoma. Main outcome measures were morbidity, visual acuity, resolution of macular exudates, and presence of VHL markers. Results: Visual acuity improved or remained stable in all patients. All 3 developed cataracts, extracted in 2 instances. Histopathological findings were typical of retinal hemangioblastoma in all cases. The cells from one patient's DNA sample showed loss of heterozygosity for the VHL gene, while no genetic abnormalities were detected in the other patient's DNA sample. Conclusions: Our patients' favorable outcomes suggest that surgical resection is an option for patients with large retinal hemangioblastomas. In addition, ours may be the first report of retinal hemangioblastoma unassociated with a VHL mutation.

AB - Objective: To report the clinical outcomes and molecular genetics of nongermline retinal hemangioblastoma managed by surgical resection. Methods: Retrospective case series of 3 patients aged 16 to 46 years treated at a tertiary care referral center (Casey Eye Institute, Portland, Oregon). Tumors 7 to 9 mm in diameter were removed from 3 consecutive eyes (in 3 patients) via internal en bloc surgical resection using a bimanual technique. Samples of DNA from 2 of 3 tumors were tested for von Hippel-Lindau gene (VHL) mutations as a clue to the molecular basis for spontaneously occurring hemangioblastoma. Main outcome measures were morbidity, visual acuity, resolution of macular exudates, and presence of VHL markers. Results: Visual acuity improved or remained stable in all patients. All 3 developed cataracts, extracted in 2 instances. Histopathological findings were typical of retinal hemangioblastoma in all cases. The cells from one patient's DNA sample showed loss of heterozygosity for the VHL gene, while no genetic abnormalities were detected in the other patient's DNA sample. Conclusions: Our patients' favorable outcomes suggest that surgical resection is an option for patients with large retinal hemangioblastomas. In addition, ours may be the first report of retinal hemangioblastoma unassociated with a VHL mutation.

UR - http://www.scopus.com/inward/record.url?scp=34548624380&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548624380&partnerID=8YFLogxK

U2 - 10.1001/archopht.125.9.1189

DO - 10.1001/archopht.125.9.1189

M3 - Article

C2 - 17846357

AN - SCOPUS:34548624380

VL - 125

SP - 1189

EP - 1193

JO - JAMA Ophthalmology

JF - JAMA Ophthalmology

SN - 2168-6165

IS - 9

ER -